Industry Experts

Sabrina Vollers is currently a Director on the site leadership team of Ichnos Sciences SA (La Chaux- de-Fonds, CH), which she joined when it was Glenmark Pharmaceuticals in 2018. Since 2023, Dr. Vollers has been head of Drug Product and Analytical Development, comprising development teams for physico-chemical, MS, bioanalytics, and formulation for early phase bi- and multi-specific antibody therapeutics. Dr. Vollers obtained her PhD in Biochemistry and Molecular Pharmacology from the University of Massachusetts Medical School (USA) in 2013, where her thesis focused on the kinetics of human glucose transporters. After a first postdoc in diabetes genomics and physiology at the University of Lausanne (CH), she established a pipeline for characterization of de novo protein vaccines at the EPFL (CH).